v3.26.1
INCOME TAX (Tables)
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of Loss Before Income Tax Taxes and Current Tax (Benefit) Expense

  ​ ​ ​

Year ended December 31,

(in thousands)

  ​ ​ ​

2025

  ​ ​ ​

2024

Income (loss) before income taxes:

  ​

 

  ​

Domestic

$

(26,486)

$

(39,830)

Foreign

 

8

 

Total loss before taxes

$

(26,478)

$

(39,830)

Current taxes:

 

  ​

 

  ​

Federal

$

$

State

 

4

 

4

Foreign

 

 

Total current taxes

$

4

$

4

Deferred taxes:

 

  ​

 

  ​

Federal

$

$

State

 

 

Foreign

 

 

Total deferred taxes

 

 

Total

$

4

$

4

Schedule of Effective Income Tax Rate Reconciliation

  ​ ​ ​

Year ended December 31,

 

2025

 

  ​ ​ ​

$ Amount

  ​ ​ ​

%

 

Federal income tax provision at statutory rate

$

(5,560)

 

21.00

%

State income tax provision, net of federal benefit (1)

 

3

 

(0.01)

%

Permanent differences

 

407

 

(1.54)

%

Change in valuation allowances

 

(4,305)

 

17.42

%

Change in unrecognized tax benefits

 

(120)

 

0.45

%

R&D tax credit

 

(1,874)

 

7.08

%

Other:

 

  ​

 

  ​

Federal NOL carryforward deferred tax asset write-off

 

8,441

 

(31.88)

%

R&D tax credit carryforward deferred tax write-off

 

2,106

 

(7.96)

%

Share-based compensation deferred tax asset write-off

 

906

 

(4.58)

%

Effective income tax rate

$

4

 

(0.02)

%

(1)The state that contributed to the majority (greater than 50%) of the tax effect in this category was New Jersey.

  ​ ​ ​

Year ended December 31,

 

 

2024

Federal income tax provision at statutory rate

 

21.00

%

State income tax provision, net of federal benefit

 

(0.01)

%

Permanent differences

 

(0.06)

%

Change in valuation allowances

 

(20.94)

%

Effective income tax rate

 

(0.01)

%

Schedule of Deferred Tax Assets and Liabilities

December 31,

(in thousands)

  ​ ​ ​

2025

  ​ ​ ​

2024

Deferred tax assets:

Net operating loss carryforwards

$

76,431

$

75,922

Tax credit carryforwards

 

7,060

 

7,171

Section 174 expenses

 

13,485

 

14,720

Share-based compensation

 

1,266

 

2,217

Accrued expenses and other

 

441

 

649

Total gross deferred tax assets

 

98,683

 

100,679

Less: valuation allowance

 

(98,683)

 

(100,679)

Net deferred tax assets

$

$

Schedule of Unrecognized Tax Benefits Roll Forward

The following table summarizes the activity of the Company’s unrecognized tax benefits (in thousands):

Balance at January 1, 2024

  ​ ​ ​

$

2,458

Reductions for prior year positions

 

(3)

Additions for current year positions

 

111

Balance at December 31, 2024

$

2,566

Additions for prior year positions

 

306

Additions for current year positions

 

163

Reductions related to write off of R&D Tax Credit from Deferred Tax Asset

 

(589)

Balance at December 31, 2025

$

2,446